Cargando…
Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats
Focal segmental glomerulosclerosis (FSGS) is a scarring process associated with chronic low‐grade inflammation ascribed to toll‐like receptor (TLR) activation and monocyte migration. We developed synthetic, small‐molecule lecinoxoids, VB‐201 and VB‐703, that differentially inhibit TLR‐2‐ and TLR‐4‐m...
Autores principales: | Yacov, Niva, Feldman, Boris, Volkov, Alexander, Ishai, Eti, Breitbart, Eyal, Mendel, Itzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379519/ https://www.ncbi.nlm.nih.gov/pubmed/30125459 http://dx.doi.org/10.1111/bcpt.13114 |
Ejemplares similares
-
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis
por: Mendel, Itzhak, et al.
Publicado: (2016) -
Newly characterized motile sperm domain‐containing protein 2 promotes human breast cancer metastasis
por: Salem, Yaniv, et al.
Publicado: (2018) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007) -
Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007) -
Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016)